More than 160,000 people suffering from diabetic foot ulcers in 26 countries have been successfully treated in the past seven years with Cuban biotech drug Heberprot-P, according to specialists. During the 16th National Workshop for the Integral Attention to Diabetic Patients (Paipupd), taking place this week in the eastern Cuban city of Santiago de Cuba,
↧